Efficacy and safety of PD-1 and PD-L1 inhibitors combined with chemotherapy in randomized clinical trials among triple-negative breast cancer

Overview of attention for article published in Frontiers in Pharmacology, September 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 5,779 followers.

New Research: Efficacy and safety of PD-1 and PD-L1 inhibitors combined with chemotherapy in randomized clinical trials among triple-negative breast cancer https://t.co/WO6nEA2XDg #pharmacology

16 Sep 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.